Micah Spencer
Podiatrist · Mishawaka, INNPI 1558850164
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (54.8%), education and food and beverage — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Stryker at 53.5% of the total. Reporting peaked in 2019 at $2,425 and has fallen 95.3% since, to $114 in 2025.
Across 56 payments — averaging $115.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$3K
- Arthrex$2K
- Crossroads Orthopedics, LLC$517
- Organogenesis Inc.$129
- Treace Medical Concepts, Inc.$123
- Medline Industries LP$123
- plus $498 from 8 others
What the payments were for
- Travel & lodging$3,55155%
- Food & beverage$1,32620%
- Education$1,59925%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 28 | $3,463 |
| Arthrex | 3 | $1,623 |
| Crossroads Orthopedics, LLC | 2 | $517 |
| Organogenesis Inc. | 3 | $129 |
| Treace Medical Concepts, Inc. | 3 | $123 |
| Medline Industries LP | 1 | $123 |
| Orthofix Medical, Inc. | 3 | $100 |
| Zimmer Biomet | 5 | $94 |
| Amgen | 1 | $86 |
| Integra Lifesciences Corporation | 2 | $84 |
| Paragon 28, Inc. | 2 | $68 |
| Acera Surgical, Inc. | 1 | $27 |
| Nevro Corp. | 1 | $24 |
| Paratek Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROPHECY$1,566
- PRIME SERIES$1,173
- INFINITY$692
- MAKO$166
- Hyalomatrix Wound Device$123
- INBONE$122
How this compares
$6,476 in reported general payments places this provider in the 80th percentile of 131 podiatrist providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 110 | $1,723 |
| Terbinafine Hcl | 70 | $786 |
| Cephalexin | 24 | $560 |
| Doxycycline Hyclate | 60 | $523 |
| Ketoconazole | 20 | $253 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 14 | $160 |
| Duloxetine Hcl | 15 | $141 |
| Gabapentin | 16 | $119 |
| Diclofenac Sodium | 16 | $115 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 12 | $72 |
| Meloxicam | 16 | $25 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Mishawaka
- Jason GroveMishawaka$7K
- Christopher EberleMishawaka$6K
- Andrew RaderJasper$726K
- Anthony MillerIndianapolis$292K
- Corey GrohIndianapolis$57K
- Jeffrey StevensIndianapolis$56K
- James VestileTipton$44K
- Andrew KapsalisAvon$37K
- Scott HoffmanAvon$22K
- John RachoyMunster$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.